• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Vicarious Surgical Inc. (Amendment)

    12/28/22 8:28:30 AM ET
    $RBOT
    Industrial Specialties
    Health Care
    Get the next $RBOT alert in real time by email
    SC 13G/A 1 tm2233506d1_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

    Vicarious Surgical Inc.

    (Name of Issuer)

     

    Class A common stock, par value $0.0001 per share

    (Title of Class of Securities)

     

    92561V109

    (CUSIP Number)

     

    November 16, 2022

    Date of Event Which Requires Filing of this Statement

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ¨Rule 13d-1(b)
    xRule 13d-1(c)
    ¨Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    SCHEDULE 13G

     

    CUSIP No.
    92561V109    

     

    1

    Name of Reporting Person:

     

    Bright Insight Holdings Limited

    2

    Check the Appropriate Box if a Member of a Group

    (a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    Citizenship or Place of Organization

     

    British Virgin Islands

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    6,171,674 (1)

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    6,171,674 (1)

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED

     

    6,171,674 (1)

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    4.9%(2)

    12

    TYPE OF REPORTING PERSON

     

    OO

     

    (1) Consists of (i) 2,107,864 shares of Class A common stock, par value $0.0001 per share, of Vicarious Surgical Inc. (the “Issuer”) held by Bright Insight Holdings Limited and (ii) 4,063,810 shares of Class A common stock of the Issuer underlying warrants held by Bright Insight Holdings Limited which are exercisable within 60 days of the date hereof. Pursuant to the Warrant Agreement, on November 16, 2022, Bright Insight Holdings Limited provided notice to the Issuer limiting Bright Insight Holdings Limited’s ability to exercise its warrants such that its ownership of the outstanding Class A common stock of the Issuer shall not exceed 4.9% (the “Blocker”). Bright Insight Holdings Limited disclaims any beneficial ownership of the securities reported herein except to the extent of any pecuniary interest it may have therein, directly or indirectly.

     

    (2) Based on a total of 106,782,361 shares of Class A common stock outstanding consisting of (i) 102,718,551 shares of Class A common stock outstanding as of November 1, 2022, as reported in the Issuer’s Form 10-Q (File No. 001-39384) filed with the Securities and Exchange Commission on November 7, 2022 and (ii) 4,063,810 shares of Class A common stock of the Issuer underlying warrants held by Bright Insight Holdings Limited which are exercisable within 60 days of the date hereof, excluding the warrants held by Bright Insight Holdings Limited subject to the Blocker.

     

     

     

     

    CUSIP No.
    92561V109  

     

    1

    Name of Reporting Person:

     

    Chen-Chi Liu

    2

    Check the Appropriate Box if a Member of a Group

    (a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    Citizenship or Place of Organization

     

    Taiwan, Republic of China

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    6,171,674 (1)(2)

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    6,171,674 (1)(2)

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED

     

    6,171,674 (1)(2)

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    4.9%(3)

    12

    TYPE OF REPORTING PERSON

     

    IN

     

    (1) The securities reported herein are held directly by Bright Insight Holdings Limited. Chen-Chi Liu is the Director of Bright Insight Holdings Limited and shares voting and dispositive power over the securities held directly by Bright Insight Holdings Limited. As a result, Mr. Liu may be deemed to have or share beneficial ownership of the securities held directly by Bright Insight Holdings Limited.

      

    (2) Consists of (i) 2,107,864 shares of Class A common stock of the Issuer held by Bright Insight Holdings Limited and (ii) 4,063,810 shares of Class A common stock of the Issuer underlying warrants held by Bright Insight Holdings Limited which are exercisable within 60 days of the date hereof. Mr. Liu disclaims any beneficial ownership of the securities reported herein except to the extent of any pecuniary interest he may have therein, directly or indirectly.

     

    (3) Based on a total of 106,782,361 shares of Class A common stock outstanding consisting of (i) 102,718,551 shares of Class A common stock outstanding as of November 1, 2022, as reported in the Issuer’s Form 10-Q (File No. 001-39384) filed with the Securities and Exchange Commission on November 7, 2022 and (ii) 4,063,810 shares of Class A common stock of the Issuer underlying warrants held by Bright Insight Holdings Limited which are exercisable within 60 days of the date hereof, excluding the warrants held by Bright Insight Holdings Limited subject to the Blocker.

     

     

     

     

    Item 1.

     

    (a)Name of Issuer:

     

    Vicarious Surgical Inc. (the “Issuer”)

     

    (b)Address of Issuer’s Principal Executive Offices:

     

    78 Fourth Avenue, Waltham, Massachusetts 02451

     

    Item 2.

     

    (a)Name of Person Filing:

     

    This statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”) pursuant to a Joint Filing Agreement previously filed as an exhibit to the Schedule 13G filed with the Reporting Persons July 25, 2022:

     

    1.Bright Insight Holdings Limited; and

     

    2.Chen-Chi Liu.

     

    Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.

     

    (b)Address of Principal Business Office or, if None, Residence:

     

    The principal business address of each Reporting Person is as follows:

     

    No. 26, Ln. 201, Kangle Street.
    Nelhu District., Taipei, City 114
    Taiwan Republic of China

     

    (c)Citizenship:

     

    See responses to row 4 of the cover page for each Reporting Person.

     

    (d)Title and Class of Securities:

     

    Common Stock, $0.0001 par value per share

     

    (e)CUSIP No.:

     

    92561V109

     

    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    Not applicable.

     

     

     

     

    Item 4.Ownership

     

    (a)Amount Beneficially Owned: See the response to row 9 of the cover page for each Reporting Person.

     

    (b)Percent of Class: See the response to row 11 of the cover page for each Reporting Person.

     

    (c)Number of shares as to which such person has:

     

    (i)Sole power to vote or to direct the vote: See the response to row 5 of the cover page for each Reporting Person.

     

    (ii)Shared power to vote or to direct the vote: See the response to row 6 of the cover page for each Reporting Person.

     

    (iii)Sole power to dispose or to direct the disposition of: See the response to row 7 of the cover page for each Reporting Person
       
    (iv)Shared power to dispose or to direct the disposition of: See the response to row 8 of the cover page for each Reporting Person.

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

     

    Item 6.Ownership of more than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

     

    Not Applicable.

     

    Item 8.Identification and Classification of Members of the Group.

     

    Not Applicable.

     

    Item 9.Notice of Dissolution of Group.

     

    Not Applicable.

     

    Item 10.Certifications.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: December 28, 2022

     

    BRIGHT INSIGHT HOLDINGS LIMITED

     

    By: /s/ Chen-Chi Liu  
    Name: Chen-Chi Liu  
    Title: Director  

     

    /s/ Chen-Chi Liu  
    Name: Chen-Chi Liu  

     

     

     

    Get the next $RBOT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RBOT

    DatePrice TargetRatingAnalyst
    3/4/2022$16.00 → $7.00Overweight → Neutral
    Piper Sandler
    1/7/2022$16.00Outperform
    Credit Suisse
    12/7/2021$15.00Outperform
    Cowen & Co.
    11/5/2021$15.00Buy
    Canaccord Genuity
    10/18/2021$15.00Buy
    BTIG
    10/7/2021$16.00Overweight
    Piper Sandler
    More analyst ratings

    $RBOT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vicarious Surgical downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Vicarious Surgical from Overweight to Neutral and set a new price target of $7.00 from $16.00 previously

    3/4/22 4:51:18 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    Credit Suisse initiated coverage on Vicarious Surgical with a new price target

    Credit Suisse initiated coverage of Vicarious Surgical with a rating of Outperform and set a new price target of $16.00

    1/7/22 7:09:02 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    Cowen & Co. initiated coverage on Vicarious Surgical with a new price target

    Cowen & Co. initiated coverage of Vicarious Surgical with a rating of Outperform and set a new price target of $15.00

    12/7/21 7:31:51 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    SEC Filings

    View All

    SEC Form 10-Q filed by Vicarious Surgical Inc.

    10-Q - Vicarious Surgical Inc. (0001812173) (Filer)

    8/12/25 5:00:50 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Vicarious Surgical Inc. (0001812173) (Filer)

    8/12/25 4:16:02 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Vicarious Surgical Inc. (0001812173) (Filer)

    7/31/25 4:30:50 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Ahmad Fuad

    4 - Vicarious Surgical Inc. (0001812173) (Issuer)

    8/11/25 9:04:11 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Chief Technology Officer Khalifa Sammy

    4 - Vicarious Surgical Inc. (0001812173) (Issuer)

    8/11/25 9:03:49 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Director Tang Donald F

    4 - Vicarious Surgical Inc. (0001812173) (Issuer)

    8/11/25 9:03:28 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Leadership Updates

    Live Leadership Updates

    View All

    Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer

    Ms. Romano brings decades of experience with a strong track record in financial strategy and corporate development Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the appointment of Sarah Romano as Chief Financial Officer (CFO), effective April 1, 2025. Ms. Romano will oversee Vicarious Surgical's financial strategy, leveraging decades of financial leadership experience in capital markets. With exceptional strategic acumen, Ms. Romano has a proven record of driving growth and value creation in public companies, particularly in the h

    3/13/25 8:30:00 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company President

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS))), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that Randy Clark has been appointed President effective today, January 29, 2024. As Vicarious Surgical prepares for its next phase of growth following the anticipated finalization of the Vicarious Surgical Version 1.0 System ("V1.0"), the newly established role of President is designed to fortify organizational alignment and focus on the Company's long-term needs and objectives. Reporting to Chief Executive Officer Adam Sachs, Mr. Clark will a

    1/29/24 8:30:00 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Announces Changes to Board of Directors

    Victoria Carr-Brendel, Ph.D. Elected to Board of Directors Tech-Focused Venture Capitalist Phil Liang to Resign Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the appointment of Victoria Carr-Brendel, Ph.D. to the Vicarious Surgical Board of Directors effective today, January 23, 2023. The Company also announced the resignation of technology-focused venture capitalist Phil Liang from the Vicarious Surgical Board of Directors effective as of today. "On behalf of the board, I'd like to thank Phil for his critical guidance and expertise as Vicari

    1/23/23 4:10:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Financials

    Live finance-specific insights

    View All

    Vicarious Surgical Reports Second Quarter 2025 Financial Results

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the second quarter ended June 30, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, August 12, 2025. "Leading Vicarious Surgical from its earliest days through key development milestones has been an extraordinary experience. I'm incredibly proud of the foundation we've built. As I move into the role of President, I'm pleased to welcome Stephen as CEO," said Adam Sachs, President, Co-Founder, and Board member. "His depth of experienc

    8/12/25 4:15:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical to Report Second Quarter 2025 Financial Results on August 12, 2025

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the second quarter ended June 30, 2025 after the market closes on Tuesday, August 12, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing +1 833-470-1428 for domestic callers or +1 404-975-4839 for international callers, using access code: 572850. A live and archived webcast of the event will be available at https://inves

    7/29/25 4:05:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Reports First Quarter 2025 Financial Results

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, May 12, 2025. "Following years of meticulous work to develop and advance our surgical system and proprietary decoupled actuating technology, we are just a few quarters away from our biggest milestone yet - our first clinical patients. 2025 will be the year Vicarious Surgical evolves into a clinical-stage company and demonstrates the immense value of o

    5/12/25 4:05:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Vicarious Surgical Inc. (Amendment)

    SC 13G/A - Vicarious Surgical Inc. (0001812173) (Subject)

    2/13/24 4:36:42 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Vicarious Surgical Inc. (Amendment)

    SC 13G/A - Vicarious Surgical Inc. (0001812173) (Subject)

    8/15/23 10:28:36 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    SEC Form SC 13D/A filed by Vicarious Surgical Inc. (Amendment)

    SC 13D/A - Vicarious Surgical Inc. (0001812173) (Subject)

    8/9/23 5:10:57 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vicarious Surgical Reports Second Quarter 2025 Financial Results

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the second quarter ended June 30, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, August 12, 2025. "Leading Vicarious Surgical from its earliest days through key development milestones has been an extraordinary experience. I'm incredibly proud of the foundation we've built. As I move into the role of President, I'm pleased to welcome Stephen as CEO," said Adam Sachs, President, Co-Founder, and Board member. "His depth of experienc

    8/12/25 4:15:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive Officer

    Adam Sachs, Co-Founder, to Remain on as President Vicarious Surgical Inc. (NYSE:RBOT, RBOT WS)) (the "Company"), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the appointment of Stephen From as Chief Executive Officer and a member of the Company's Board of Directors (the "Board"), effective August 7, 2025. Adam Sachs, current Chief Executive Officer, Co-Founder, and a member of the Board, will remain with the Company as President, Co-Founder, and a member of the Board in an operational capacity as a member of the Company's leadership team. Mr. From brings over 20 years of leadership in the healthcare and financial

    7/31/25 4:30:00 PM ET
    $KPRX
    $RBOT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Specialties

    Vicarious Surgical to Report Second Quarter 2025 Financial Results on August 12, 2025

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the second quarter ended June 30, 2025 after the market closes on Tuesday, August 12, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing +1 833-470-1428 for domestic callers or +1 404-975-4839 for international callers, using access code: 572850. A live and archived webcast of the event will be available at https://inves

    7/29/25 4:05:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care